3 news items
Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
ELTX
23 May 24
competitors and our industry; the impact of government laws and regulations; Elicio's ability to protect its intellectual property position
Elicio Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updates
ELTX
15 May 24
and Elicio's pipeline programs; developments and projections relating to Elicio's competitors and our industry; the impact of government laws and regulations
Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry
ELTX
11 Apr 24
a rise in government funding and investments
- Prev
- 1
- Next